Hypercholesterolemia

11 competing products in clinical development for Hypercholesterolemia.

Pipeline by Phase

Pre-clinical3

Phase 31

Approved7

All Products (11)

Product	Company	Stage	Status	Hype
generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)	Yuhan	Approved	Completed	43
colesevelam HCl tablets, and simvastatin tablets + simvastatin tablets and colesevelam HCl placebo	Daiichi Sankyo	Approved	Completed	43
colesevelam HCl tablets and fenofibrate tablets + fenofibrate tablets and Welchol placebo tablets + fenofibrate tablets and Welchol placebo tablets	Daiichi Sankyo	Approved	Completed	43
colesevelam HCl + placebo	Daiichi Sankyo	Approved	Completed	43
colesevelam HCl tablets, and atorvastatin tablets + colesevelam HCl placebo tablets and atorvastatin tablets	Daiichi Sankyo	Approved	Completed	43
Colesevelam Hydrochloride + Ezetimibe + Simvastatin	Daiichi Sankyo	Approved	Completed	43
pravastatin tablets and Welchol tablets + pravastatin tablets and Welchol placebo tablets	Daiichi Sankyo	Approved	Completed	43
Evacetrapib + Ezetimibe + Atorvastatin + Placebo	Eli Lilly	Phase 3	Terminated	32
Bempedoic acid and/or its fixed-dose combination with ezetimibe	Daiichi Sankyo	Pre-clinical	Active	30
Bempedoic Acid 180Mg/Ezetimibe 10Mg Tab	Daiichi Sankyo	Pre-clinical	Completed	26
atrovastatin	Astellas Pharma	Pre-clinical	Completed	26